Cancer
Malignant Gastric Neoplasm
CI-CAN-00001130Explore in graph →
Top-level650 active trials4 approved drugs55 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00001130Explore in graph →
Clinical trials
2,844 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (232)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02638584 | Effects of Ilaprazole on Ulcer Healing Rate and Prevention of Gastrointestinal Bleeding in the Patients Undergone ESD. | completed | Phase 4 | 176 | Il-Yang Pharm. Co., Ltd.INDUSTRY | 1 | Jul 31, 2020 | clinicaltrials |
| NCT04490668 | Human Albumin and Anastomotic Leakage After Gastric Cancer Surgery | completed | — | 1,049 | Ruijin HospitalOTHER | 0 | Jul 29, 2020 | clinicaltrials |
| NCT03032224 | Analysis of Body Composition in Relation to Outcome After Surgery in a Cohort of Patients With Esophageal Cancer | completed | — | 76 | Vastra Gotaland RegionOTHER_GOV | 1 | Jul 28, 2020 | clinicaltrials |
| NCT02629315 | Carnoy's Solution Versus Formalin in Rectal and Gastric Cancer Specimens Following: a Randomized Trial | completed | N/A | 130 | Instituto do Cancer do Estado de São PauloOTHER | 0 | Jul 23, 2020 | clinicaltrials |
| NCT04481828 | Comparison With Open and Totally Laparoscopic Gastrectomy for Gastric Cancer | completed | — | 60 | Kocaeli Derince Education and Research HospitalOTHER | 1 | Jul 22, 2020 | clinicaltrials |
| NCT02443883 | A Phase 2 Study of Ramucirumab (LY3009806) in Participants With Gastric or Gastroesophageal Junction (GEJ) Cancer | completed | Phase 2 | 164 | Eli Lilly and CompanyINDUSTRY | 12 | Jun 29, 2020 | clinicaltrials |
| NCT02514551 | A Study of Ramucirumab (LY3009806) in Combination With Paclitaxel in Participants With Gastric Cancer | completed | Phase 2 | 245 | Eli Lilly and CompanyINDUSTRY | 11 | Jun 17, 2020 | clinicaltrials |
| NCT03958032 | Effects of Sarcopenia on Early Postoperative Outcomes in Patients Undergoing Surgical Treatment for Gastric Cancer | completed | — | 185 | Karadeniz Technical UniversityOTHER | 1 | Jun 16, 2020 | clinicaltrials |
| NCT04429841 | D2 Versus D1 Gastrectomy of Operable Gastric Cancer | completed | — | 148 | Alexandria UniversityOTHER | 1 | Jun 12, 2020 | clinicaltrials |
| NCT02545504 | Andecaliximab With mFOLFOX6 as First Line Treatment for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma(GAMMA-1) | completed | Phase 3 | 432 | Gilead SciencesINDUSTRY | 16 | May 26, 2020 | clinicaltrials |
| NCT03639792 | Escorting Octogenarian for Gastric Cancer Surgery | completed | — | 61 | Ruijin HospitalOTHER | 1 | May 22, 2020 | clinicaltrials |
| NCT03418298 | Prehabilitation in Patients With Esophageal or Gastric Cancers | completed | N/A | 30 | Cliniques universitaires Saint-Luc- Université Catholique de LouvainOTHER | 1 | May 21, 2020 | clinicaltrials |
| NCT01913639 | FOLFOX Plus Regorafenib in Patients With Unresectable or Metastatic Esophagogastric Cancer | completed | Phase 2 | 39 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | May 15, 2020 | clinicaltrials |
| NCT01643499 | Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies | completed | Phase 1 | 79 | University of ChicagoOTHER | 1 | May 8, 2020 | clinicaltrials |
| NCT00052910 | Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer | completed | Phase 3 | 546 | Alliance for Clinical Trials in OncologyOTHER | 2 | May 7, 2020 | clinicaltrials |
| NCT01633203 | Observational Study of Perioperative Chemotherapy in Gastric Cancer(PRECISO) | completed | — | 61 | Grupo Oncologico Cooperativo Chileno de InvestigationNETWORK | 1 | Apr 24, 2020 | clinicaltrials |
| NCT04340440 | Curative D2 vs D1 Lymphadenectomy in Operable Gastric Carcinoma | completed | N/A | 80 | University of AlexandriaOTHER | 0 | Apr 10, 2020 | clinicaltrials |
| NCT03061370 | Sarcopenia and Visceral Obesity in Esophageal and Gastric Cancer | completed | — | 317 | St. James's Hospital, IrelandOTHER | 1 | Mar 26, 2020 | clinicaltrials |
| NCT02528110 | Radical Gastrectomy and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Locally Advanced Gastric Cancer | completed | Phase 2 | 100 | Wuhan UniversityOTHER | 1 | Mar 24, 2020 | clinicaltrials |
| NCT03606928 | mFLOT Chemotherapy as First-line Treatment in GC | completed | Phase 1 / Phase 2 | 18 | Ruijin HospitalOTHER | 1 | Mar 20, 2020 | clinicaltrials |
| NCT03515356 | Exercise to Reduce Chemotherapy-Induced Peripheral Neuropathy | completed | N/A | 54 | University of Michigan Rogel Cancer CenterOTHER | 1 | Mar 9, 2020 | clinicaltrials |
| NCT02946671 | Study of Pre-operative Combination Therapy With Mogamulizumab and Nivolumab Against Solid Cancer Patients | completed | Phase 1 | 16 | Osaka UniversityOTHER | 1 | Mar 6, 2020 | clinicaltrials |
| NCT04286984 | Implementation of a Patient Blood Management Program in Gastric Cancer Surgery(IPAT) | completed | — | 1,063 | Hospital Universitari de BellvitgeOTHER | 0 | Mar 2, 2020 | clinicaltrials |
| NCT03076567 | Discovery and Validation of Plasma DNA Methylation Biomarker for Detection of Stomach Cancer | completed | — | 440 | National Cancer Institute (NCI)NIH | 1 | Feb 25, 2020 | clinicaltrials |
| NCT00439608 | Cetuximab, Paclitaxel, Carboplatin & Radiation for Esoph, Gastroesoph & Gastric Cancer | completed | Phase 2 | 60 | Brown UniversityOTHER | 1 | Feb 17, 2020 | clinicaltrials |
| NCT02415023 | A Phase Ib/2 Clinical Study of Fruquintinib Combined With Paclitaxel in the Treatment of Advanced Gastric Cancer | completed | Phase 1 / Phase 2 | 34 | Hutchison Medipharma LimitedINDUSTRY | 1 | Feb 17, 2020 | clinicaltrials |
| NCT01516944 | Perioperative Chemotherapy for Potentially Resectable Gastric Cancer | completed | Phase 2 / Phase 3 | 749 | Hebei Medical UniversityOTHER | 1 | Feb 13, 2020 | clinicaltrials |
| NCT00525785 | Preoperative Chemo and Chemoradiotherapy for Adenocarcinoma of the Stomach and Gastroesophageal Junction (GEJ) | completed | Phase 2 | 58 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 10, 2020 | clinicaltrials |
| NCT01747551 | FOLFOX +/- Ziv-Aflibercept for Esophageal and Gastric Cancer | completed | Phase 2 | 64 | Dana-Farber Cancer InstituteOTHER | 1 | Feb 10, 2020 | clinicaltrials |
| NCT02563548 | A Study of PEGylated Recombinant Human Hyaluronidase (PEGPH20) With Pembrolizumab in Participants With Selected Hyaluronan High Solid Tumors | completed | Phase 1 | 56 | Halozyme TherapeuticsINDUSTRY | 1 | Feb 7, 2020 | clinicaltrials |
| NCT01248403 | A Randomized, Double Blind Study Evaluating Paclitaxel With and Without RAD001 in Patients With Gastric Carcinoma After Prior Chemotherapy(AIO-STO-0111) | completed | Phase 3 | 300 | Krankenhaus NordwestOTHER | 1 | Jan 29, 2020 | clinicaltrials |
| NCT01846520 | Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers | completed | N/A | 200 | City of Hope Medical CenterOTHER | 1 | Jan 23, 2020 | clinicaltrials |
| NCT03159585 | To Evaluate the Efficacy of NY-ESO-1-specific T Cell Receptor Affinity Enhancing Specific T Cell in Solid Tumors | completed | Phase 1 | 6 | Zhujiang HospitalOTHER | 1 | Jan 22, 2020 | clinicaltrials |
| NCT00296322 | Trial of Adjuvant Chemotherapy for Gastric Cancer | completed | Phase 3 | 528 | Asan Medical CenterOTHER | 1 | Jan 18, 2020 | clinicaltrials |
| NCT00446290 | Study of Docetaxel, Capecitabine and Oxaliplatin in Advanced Stomach Cancer | completed | Phase 1 | 22 | Asan Medical CenterOTHER | 1 | Jan 18, 2020 | clinicaltrials |
| NCT00565370 | Capecitabine and Cisplatin (XP)+Sorafenib in Advanced Gastric Cancer (AGC): Sorafenib+XP | completed | Phase 1 / Phase 2 | 22 | Asan Medical CenterOTHER | 1 | Jan 18, 2020 | clinicaltrials |
| NCT00398398 | Study of XELOX With Cetuximab in Advanced Gastric Cancer | completed | Phase 2 | 44 | Asan Medical CenterOTHER | 1 | Jan 7, 2020 | clinicaltrials |
| NCT00915382 | Trial of 3-weekly Versus 5-weekly Schedule of S-1 Plus Cisplatin in Gastric Cancer: SOS | completed | Phase 3 | 625 | Asan Medical CenterOTHER | 1 | Jan 7, 2020 | clinicaltrials |
| NCT00976768 | Biweekly FOLFIRI in Advanced Gastric Cancer (AGC) With Failure of Prior Taxane, Fluoropyrimidine, and Cisplatin | completed | Phase 2 | 44 | Asan Medical CenterOTHER | 1 | Jan 7, 2020 | clinicaltrials |
| NCT01045538 | Study of Vorinostat Plus Capecitabine (X) and Cisplatin (P) for 1st Line Treatment of Metastatic or Recurrent Gastric Cancer: Zolinza+XP | completed | Phase 1 / Phase 2 | 45 | Asan Medical CenterOTHER | 1 | Jan 7, 2020 | clinicaltrials |
| NCT01047618 | Venous Thromboembolism in Advanced Gastric Cancer Patients | completed | — | 259 | Asan Medical CenterOTHER | 1 | Jan 7, 2020 | clinicaltrials |
| NCT01049620 | RAD001 in Combination With Capecitabine and Oxaliplatin (XELOX) in Patients With Advanced Gastric Cancer: RAD001+XELOX | completed | Phase 1 | 40 | Asan Medical CenterOTHER | 1 | Jan 7, 2020 | clinicaltrials |
| NCT01187212 | Sorafenib Trial in Advanced and/or Recurrent Gastric Adenocarcinoma: Treatment Evaluation: STARGATE | completed | Phase 2 | 195 | Asan Medical CenterOTHER | 1 | Jan 7, 2020 | clinicaltrials |
| NCT01471470 | Efficacy of Docetaxel, Capecitabine, Cisplatin, and Bevacizumab in Patients With Unresectable Advanced Gastric Cancer | completed | Phase 2 | 31 | Asan Medical CenterOTHER | 1 | Jan 7, 2020 | clinicaltrials |
| NCT01719549 | Dovitinib for Gastric Cancer With FGFR2 Amplification: GASDOVI-1 | completed | Phase 2 | 19 | Asan Medical CenterOTHER | 1 | Jan 7, 2020 | clinicaltrials |
| NCT03418428 | Intestinal Microbiome After Gastrectomy(DiGMA) | completed | — | 34 | Vilnius UniversityOTHER | 1 | Jan 2, 2020 | clinicaltrials |
| NCT02451956 | Study of AZD5363 in Combination With Paclitaxel, in Advanced Gastric Adenocarcinoma Patients Harboring PIK3CA Mutation and/or PIK3CA Amplification as a Second-line Chemotherapy | completed | Phase 2 | 21 | Samsung Medical CenterOTHER | 1 | Dec 30, 2019 | clinicaltrials |
| NCT03937440 | The Effect of Deep Neuromuscular Block on the Perioperative Stress Response Reduction and Postoperative Recovery Enhancement in Robot-assisted Stomach Cancer Surgery | completed | N/A | 46 | Yonsei UniversityOTHER | 1 | Dec 18, 2019 | clinicaltrials |
| NCT00515411 | Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma | completed | Phase 2 | 111 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 10, 2019 | clinicaltrials |
| NCT02276300 | HER2-Peptide Vaccination of Patients With Solid Tumors(HER2) | completed | Phase 1 | 2 | Technical University of MunichOTHER | 1 | Nov 20, 2019 | clinicaltrials |
Data updated 23 days agoSource updated Jul 31, 2020source: clinicaltrials